Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1.41bn | 1.30bn | 1.23bn | 1.17bn | 1.13bn | 1.08bn |
| Cost of revenue | 723m | 668m | 626m | 591m | 555m | 527m |
| Gross profit | 684m | 632m | 603m | 582m | 579m | 556m |
| Research and development | 262m | 262m | 243m | 254m | 262m | 243m |
| Selling, general and administrative | 103m | 108m | 102m | 92m | 106m | 114m |
| Operating expenses | 577m | 591m | 566m | 558m | 584m | 575m |
| Operating income | 108m | 41m | 37m | 23m | −5m | −19m |
| Pre-tax income | 102m | 33m | 34m | 27m | −4m | −26m |
| Income tax | 12m | −5m | 11m | 7m | 6m | 6m |
| Net income | 90m | 37m | 22m | 20m | −10m | −32m |
| Earnings per share | 0.59 | 0.24 | 0.15 | 0.13 | −0.06 | −0.19 |
| Earnings per share, diluted | 0.57 | 0.23 | 0.14 | 0.12 | −0.06 | −0.19 |
| Weighted average shares | 152m | 153m | 153m | 153m | 159m | 170m |
| Weighted average shares, diluted | 158m | 159m | 160m | 162m | 159m | 170m |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 542m | 682m | 735m | 969m | 467m | 421m | 584m | 755m |
| Receivables | 711m | 637m | 613m |
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 153m | — | — | 191m | — | — |
| Depreciation and amortisation | 34m | — | — |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 588m |
| 578m |
| 589m |
| 551m |
| 537m |
| Current assets | 3.45bn | 3.58bn | 3.48bn | 3.53bn | 3.47bn | 3.45bn | 3.55bn | 3.96bn |
| Goodwill | 5.29bn | 5.29bn | 5.24bn | 5.24bn | 5.24bn | 5.24bn | 5.24bn | 5.24bn |
| Total assets | 9.58bn | 9.77bn | 9.71bn | 9.85bn | 9.81bn | 9.87bn | 10.04bn | 10.51bn |
| Current liabilities | 740m | 887m | 742m | 720m | 726m | 820m | 701m | 711m |
| Long-term debt | 993m | 992m | 992m | 991m | 991m | 991m | 990m | 990m |
| Total liabilities | 1.79bn | 1.95bn | 1.82bn | 1.80bn | 1.81bn | 1.91bn | 1.81bn | 1.83bn |
| Equity | 7.78bn | 7.82bn | 7.90bn | 8.04bn | 8.00bn | 7.95bn | 8.23bn | 8.68bn |
| Shares outstanding | — | 152m | — | — | — | 153m | — | — |
| Shares issued | — | 152m | — | — | — | 153m | — | — |
| 50m |
| — |
| — |
| Share-based compensation | 137m | 158m | 149m | 139m | 155m | 148m |
| Investing cash flow | −41m | — | — | −19m | — | — |
| Share buybacks | 253m | — | — | 126m | — | — |
| Financing cash flow | −253m | — | — | −126m | — | — |